20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Viela Bio (NASDAQ:VIE) made its public debut Thursday morning, opening at $21.50 after being priced at $19 per share.
The company listed its shares on the Nasdaq under the symbol “VIE.”
Viela Bio is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases.
Viela Bio has granted the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial price to the public less underwriting discounts.
Goldman Sachs, Morgan Stanley and Cowen are acting as the joint book-running managers for this offering. Guggenheim Securities is acting as lead manager for this offering.
Related Links:
IGM Biosciences Opens Above IPO Price
Ping Identity Holding Opens Above IPO Price
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!